These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8635325)

  • 21. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of adequate initial antimicrobial therapy on mortality in critical patients with Pseudomonas aeruginosa bacteremia].
    González AL; Leal AL; Cortés JA; Sánchez R; Barrero LI; Castillo JS; Álvarez CA
    Biomedica; 2014 Apr; 34 Suppl 1():58-66. PubMed ID: 24968037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathogen of ventilator-associated pneumonia does not influence the mortality rate of surgical intensive care unit patients treated with a rotational antibiotic system.
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    Surg Infect (Larchmt); 2010 Feb; 11(1):13-20. PubMed ID: 20163258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is ventilator-associated pneumonia in trauma patients an epiphenomenon or a cause of death?
    Magnotti LJ; Croce MA; Fabian TC
    Surg Infect (Larchmt); 2004; 5(3):237-42. PubMed ID: 15684794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
    Eagye KJ; Nicolau DP; Kuti JL
    Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia.
    Afessa B; Shorr AF; Anzueto AR; Craven DE; Schinner R; Kollef MH
    Chest; 2010 May; 137(5):1015-21. PubMed ID: 20038737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance.
    Micek ST; Wunderink RG; Kollef MH; Chen C; Rello J; Chastre J; Antonelli M; Welte T; Clair B; Ostermann H; Calbo E; Torres A; Menichetti F; Schramm GE; Menon V
    Crit Care; 2015 May; 19(1):219. PubMed ID: 25944081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
    Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
    Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
    Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia.
    Rello J; Ausina V; Ricart M; Puzo C; Quintana E; Net A; Prats G
    Intensive Care Med; 1994; 20(3):193-8. PubMed ID: 8014285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case fatality rate related to nosocomial and ventilator-associated pneumonia in an ICU: a single-centre retrospective cohort study.
    Yalçınsoy M; Salturk C; Takır HB; Kutlu SB; Oguz A; Aksoy E; Balcı M; Kargın F; Mocin OY; Adıguzel N; Gungor G; Karakurt Z
    Wien Klin Wochenschr; 2016 Feb; 128(3-4):95-101. PubMed ID: 26542131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Intensive Care Med; 2006 Dec; 32(12):1970-8. PubMed ID: 16957901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An early predictor of the outcome of patients with ventilator-associated pneumonia.
    Huang KT; Tseng CC; Fang WF; Lin MC
    Chang Gung Med J; 2010; 33(3):274-82. PubMed ID: 20584505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-resistant Pseudomonas aeruginosa and mortality in mechanically ventilated ICU patients.
    Denis JB; Lehingue S; Pauly V; Cassir N; Gainnier M; Léone M; Daviet F; Coiffard B; Baron S; Guervilly C; Forel JM; Roch A; Papazian L
    Am J Infect Control; 2019 Sep; 47(9):1059-1064. PubMed ID: 30962023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital and long-term outcomes of ICU-treated severe community- and hospital-acquired, and ventilator-associated pneumonia patients.
    Karhu J; Ala-Kokko TI; Ylipalosaari P; Ohtonen P; Laurila JJ; Syrjälä H
    Acta Anaesthesiol Scand; 2011 Nov; 55(10):1254-60. PubMed ID: 22092131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
    Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
    Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia.
    Rello J; Rodriguez A; Torres A; Roig J; Sole-Violan J; Garnacho-Montero J; de la Torre MV; Sirvent JM; Bodi M
    Eur Respir J; 2006 Jun; 27(6):1210-6. PubMed ID: 16510452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classification.
    Micek ST; Kollef MH; Torres A; Chen C; Rello J; Chastre J; Antonelli M; Welte T; Clair B; Ostermann H; Calbo E; Wunderink R; Menichetti F; Schramm G; Menon V
    Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1190-7. PubMed ID: 26190444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerosolized tobramycin for Pseudomonas aeruginosa ventilator-associated pneumonia in patients with acute respiratory distress syndrome.
    Migiyama Y; Hirosako S; Tokunaga K; Migiyama E; Tashiro T; Sagishima K; Kamohara H; Kinoshita Y; Kohrogi H
    Pulm Pharmacol Ther; 2017 Aug; 45():142-147. PubMed ID: 28450200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exoenzyme Y Contributes to End-Organ Dysfunction Caused by
    Wagener BM; Anjum N; Christiaans SC; Banks ME; Parker JC; Threet AT; Walker RR; Isbell KD; Moser SA; Stevens T; Alexeyev MF; Audia JP; Richter W; Hardy KS; Saleh LA; Morgan C; Pittet JF
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.